Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Intensive Care Medicine|October 31, 2001
Intra-observer variability in APACHE II scoringK H Polderman, H M Christiaans, J P Wester, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week resultsS Schleibner, M Krauss, K Wagner, et al.Journal of Pharmaceutical and Biomedical Analysis|December 23, 2006
Therapeutic drug monitoring of tacrolimus with the dried blood spot methodK Hoogtanders, J van der Heijden, M Christiaans, et al.Journal of Medicinal Chemistry|September 20, 2002
Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitorsErik A A Wallén, Johannes A M Christiaans, Markus M Forsberg, et al.Journal of Pharmaceutical and Biomedical Analysis|January 22, 2009
Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometryJ van der Heijden, Y de Beer, K Hoogtanders, et al.Journal of Medicinal Chemistry|October 3, 2003
New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amidesErik A A Wallén, Johannes A M Christiaans, Elina M Jarho, et al.Bioorganic & Medicinal Chemistry|February 5, 2015
Synthesis, structure activity relationship, radiolabeling and preclinical evaluation of high affinity ligands for the ion channel of the N-methyl-d-aspartate receptor as potential imaging probes for positron emission tomographyPieter J Klein, Johannes A M Christiaans, Athanasios Metaxas, et al.Journal of Medicinal Chemistry|July 22, 2005
Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactionsElina M Jarho, Erik A A Wallén, Johannes A M Christiaans, et al.Bioorganic & Medicinal Chemistry|August 7, 2003
Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitorsErik A A Wallén, Johannes A M Christiaans, Taija J Saarinen, et al.Nuclear Medicine and Biology|May 22, 2017
Synthesis, radiolabeling and preclinical evaluation of a [11C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-D-aspartate receptorPieter J Klein, Robert C Schuit, Athanasios Metaxas, et al.Pageof 3